Vandetanib

Vandetanib is a specific inhibitor of Flk-1 and Flt-4.

443913-73-3

N- (4-bromo-2-fluorophenyl) -6-methoxy-7-[ (1-methylpiperidin-4-yl) methoxy]quinazolin-4-amine

41116105

Inhibitor

Synthetic

Cell Signaling | Cancer | Apoptosis | Cardiovascular System | Cancer Growth Inhibitors | Growth Factor Receptor Inhibitors

≥98% (HPLC)

0.01

Yellow solid

Soluble in DMSO (30 mg/ml) or EtOH (10 mg/ml)

C22H24BrFN4O2

475.4

Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

1. Bruns C.J., et al. (2000) Clin. Cancer. Res: J. Am. Assoc. Cancer Res. 6(5): 1936–1948.